Role of intelligent/interactive qualitative and quantitative analysis-three-dimensional estimated model in donor-recipient size mismatch following deceased donor liver transplantation

Table 2 Univariate and multivariate logistic regression to predict massive intraoperative blood loss

	Univariate			Multivariate
	OR	95% CI	P value	OR	95% CI	P value
Recipient age	1.038	1.007-1.070	0.017			0.106
Male	0.835	0.336-2.074	0.697			0.815
sTLVi ≥ 1.24	22.00	4.804-100.8	< 0.001	18.43	3.809-89.15	< 0.001
Donor age	1.014	0.986-1.042	0.340
MD-FR combination	1.873	0.650-5.396	0.245
FD-MR combination	0.698	0.238-2.046	0.513
Graft steatosis (< 60%)	2.187	0.903-5.297	0.083
Cold ischemia time	1.005	0.815-1.239	0.963
DRI	1.074	0.437-2.644	0.876
HBV/HCV	1.225	0.564-2.661	0.608
ALD	11.82	1.535-90.99	0.018	9.371	1.112-78.98	0.040
DILF	0.165	0.406-0.586	0.005	0.226	0.052-0.983	0.047
Hepatic carcinoma	1.422	0.615-3.288	0.410
Gastrointestinal bleeding	2.393	1.104-5.188	0.027	3.954	1.502-10.41	0.005
Moderate or severe ascites	1.065	0.502-2.261	0.869
History of open upper abdominal surgery	2.108	0.737-6.032	0.164
Platelet count	1.000	0.955-1.005	0.914
PT	1.011	0.976-1.045	0.577
Child-Pugh grade C	2.347	0.961-5.731	0.061
MELD score	1.012	0.975-1.052	0.526
Anhepatic phase time	1.020	0.975-1.067	0.396

OR: Odds ratio; 95%CI: 95% confidence interval; sTLVi: Standard total liver volume index; MD-FR: Male donor-female recipient; FD-MR: Female donor-male recipient; DRI: Donor risk index; HBV: Hepatitis B virus; HCV: Hepatitis C virus; ALD: Alcoholic liver disease; DILF: Drug-induced liver failure; PT: Prothrombin time; MELD: Model for end-stage liver disease.